RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @rcr_pereira: 1 year ago anyone thinking this drug did anything for COVID was delusional. Still thinking it does something 1 year on wit…
Sem mais.
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
1 year ago anyone thinking this drug did anything for COVID was delusional. Still thinking it does something 1 year on with all the evidence available now? Unfathomable.
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @cochranecollab: #Ivermectin for #COVID19? “While lab results showed some promise, real-life outcomes suggest no or very little impact o…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @stevenlimcl: Updated Cochrane review on IVM in Covid-19. I-TECH Study contributed to the latest analysis. We reached out to Cochrane te…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @stevenlimcl: Updated Cochrane review on IVM in Covid-19. I-TECH Study contributed to the latest analysis. We reached out to Cochrane te…
RT @stevenlimcl: Updated Cochrane review on IVM in Covid-19. I-TECH Study contributed to the latest analysis. We reached out to Cochrane te…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @leandrotessler: Quanto mais estudos aparecem sobre ivermectina contra covid maior a certeza de que ela não tem efeito algum. Saiu a nov…
Quanto mais estudos aparecem sobre ivermectina contra covid maior a certeza de que ela não tem efeito algum. Saiu a nova revisão sistemática da @CochraneLibrary.
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @stevenlimcl: Updated Cochrane review on IVM in Covid-19. I-TECH Study contributed to the latest analysis. We reached out to Cochrane te…
Progress to build evidence-based practice on #ivermectin for #COVID19 ! Glad that Malaysia contributed via I-TECH study. More than 30 trials ongoing globally! @JAMAInternalMed @CochraneLibrary
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
👉
RT @stevenlimcl: Updated Cochrane review on IVM in Covid-19. I-TECH Study contributed to the latest analysis. We reached out to Cochrane te…
Updated Cochrane review on IVM in Covid-19. I-TECH Study contributed to the latest analysis. We reached out to Cochrane team early to share our data. Scientific communication is key in pandemic era. Congrats M Popp et al! @Khairykj @DGHisham @drkalai61 htt
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
RT @lcos3060: É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os…
É cansativo. É meio que óbvio. Mas uma revisão @CochraneLibrary sobre ivermectina concluiu que não serve pra COVID. Nota: os estudos fraudados não foram incluídos, ok? Publicado HOJE! Em caso de mimimi, envie email para: [email protected].">@cochrane.org">[email protected]. https://t.co
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
RT @GidMK: Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty…
Updated Cochrane review into ivermectin for COVID-19 just dropped. Results: - uncertain about inpatients - moderate certainty ivm "probably has little or no benefit on all-cause mortality" for outpatients - no evidence on prophylaxis https://t.co/eeF0
RT @cochranecollab: #Ivermectin for #COVID19? “While lab results showed some promise, real-life outcomes suggest no or very little impact o…
@masimaux @alexandrosM @RemnantMd Look at how they prepared the new plot, Rezai is not included yet, but they already changed the outcome "participants with new need for invasive mechanical ventilation" to "participants with new need for invasive mechanica
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @Cochrane_IDG: Updated @Cochrane_IDG review on #ivermectin for preventing and treating #COVID19. Access the full-text open access review…
RT @cochranecollab: #Ivermectin for #COVID19? “While lab results showed some promise, real-life outcomes suggest no or very little impact o…
@real_seeking @cochranecollab @Cochrane_IDG @LSTMnews Cochrane uses GRADE, a systematic approach to rate the evidence included our systematic reviews and other evidence syntheses. https://t.co/l18ljAMDNf Again, we welcome you submit review specific commen
@real_seeking @cochranecollab @Cochrane_IDG @LSTMnews We welcome comments on specific reviews, please see here https://t.co/INZRaYIxZm For this review, you can submit your comment/concerns at https://t.co/oCPxxTRbuY so that it may go through the proper ch
RT @cochranecollab: #Ivermectin for #COVID19? “While lab results showed some promise, real-life outcomes suggest no or very little impact o…
RT @COVID_Evidence: PubMed: Ivermectin for preventing and treating COVID-19: BACKGROUND: Ivermectin, an antiparasitic agent, inhibits the…
#Ivermectin for #COVID19? “While lab results showed some promise, real-life outcomes suggest no or very little impact on mortality rates, illness, & length of infection.” 📚 Updated @Cochrane_IDG - https://t.co/lrtnw1Tc9v 📃 @LSTMnews press release - ht
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
Ivermectina para la prevención y el tratamiento de la covid‐19 - Popp, M - 2022 | Cochrane Library https://t.co/ae5AjR9rDd
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @Cochrane_IDG: Updated @Cochrane_IDG review on #ivermectin for preventing and treating #COVID19. Access the full-text open access review…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @mintimetz: Update of the most talked about review in the history of the @CochraneLibrary. There remains no evidence to support the use…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…
RT @EARL_COVID19_tw: 新型コロナウイルス感染症に対するイベルメクチンは,外来患者においては有益性を示せていない.コクランメタ解析(Cochrane Database Syst Rev 2022;6:CD015017) https://t.co/pO4D24v…